ACAD

ACADIA PHARMACEUTICALS INC

Healthcare | Mid Cap

$0.08

EPS Forecast

$284.1

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31T00:00:00 soon
PTCTPtc Therapeutics IncINVAInnoviva IncQUREUniqure NvPBHPrestige Consumer Healthcare IncUTHRUnited Therapeutics CorpPCRXPacira Biosciences IncPAHCPhibro Animal Health Corp